PUBLIC PREFERENCES FOR ORPHAN DRUG FUNDING: RESULTS OF SUBGROUP ANALYSES

被引：0
|
作者：
Korchagina, D.
Aballea, S. [1 ]
Millier, A. [1 ]
Thokagevistk, K. [1 ]
Toumi, M. [2 ]
机构：
[1] Creativ Ceut, Paris, France
[2] Aix Marseille Univ, Marseille, France
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.853
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY39
引用
收藏
页码：S112 / S112
页数：1
相关论文
共 50 条
  • [21] Public-private drug ventures get funding
    Jarvis, Lisa
    CHEMICAL & ENGINEERING NEWS, 2006, 84 (22) : 9 - 9
  • [22] Pharmaceutical drug development: high drug prices and the hidden role of public funding
    Stephanie Annett
    Biologia Futura, 2021, 72 : 129 - 138
  • [23] PREVENTION OR TREATMENT? PREFERENCES OF THE AUSTRALIAN PUBLIC FOR HEALTH TECHNOLOGY ASSESSMENT FUNDING CRITERIA
    Whitty, J. A.
    Ratcliffe, J.
    Scuffham, P. A.
    VALUE IN HEALTH, 2012, 15 (07) : A306 - A306
  • [24] Pharmaceutical drug development: high drug prices and the hidden role of public funding
    Annett, Stephanie
    BIOLOGIA FUTURA, 2021, 72 (02) : 129 - 138
  • [25] Application of a Stated Choice Approach to Assessing Public Preferences for Wildlife Conservation Funding
    Dayer, Ashley A.
    Bright, Alan D.
    Teel, Tara L.
    Manfredo, Michael J.
    HUMAN DIMENSIONS OF WILDLIFE, 2016, 21 (05) : 379 - 390
  • [26] Frailty in clinical drug trials: Frailty assessments, subgroup analyses and outcomes
    Nguyen, Tu N.
    Ahmad, Fahed
    Lindley, Richard I.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025, 91 (01) : 8 - 22
  • [27] SCOPE REVIEW OF ORPHAN DRUG PUBLIC POLICIES AND LEGISLATION IN LATIN AMERICA
    Chaves Restrepo, A. P.
    Vergara, C.
    Troncoso, D.
    Rosselli, D.
    VALUE IN HEALTH, 2018, 21 : S467 - S467
  • [28] Impact of Oncology Drug Review Times on Public Funding Recommendations
    Hussain, Marya
    Wong, Chelsea
    Taguedong, Eddy
    Verma, Saurav
    Mahsin, Md
    Karim, Safiya
    Lee-Ying, Richard
    Ezeife, Doreen A.
    CURRENT ONCOLOGY, 2023, 30 (08) : 7706 - 7712
  • [29] Timeliness of the oncology drug review process for public funding in Canada
    Younis, T.
    Skedgel, C.
    CURRENT ONCOLOGY, 2017, 24 (05) : 279 - 281
  • [30] MULTICENTER TRIAL OF HEMODILUTION IN ACUTE ISCHEMIC STROKE - RESULTS OF SUBGROUP ANALYSES
    ASPLUND, K
    STROKE, 1988, 19 (04) : 464 - 471
12345